Synplogen
Kobe, JP · 2 known investors
Synplogen is a synthetic biology startup spun out of Kobe University that offers custom artificial gene synthesis and DNA library construction services using its proprietary OGAB and Combinatorial-OGAB (Combi-OGAB) DNA assembly methods. It also operates a gene-therapy biofoundry that designs, develops, and analyzes gene-therapy products such as viral vectors, including CMC development work.
Founders & leadership
柘
柘植謙爾取締役 / Founder (Executive Research Fellow)
山
山本一彦代表取締役社長 兼 CEO
山
山田尚之常務取締役 CTO
岩
岩田清和取締役 COO
齋
齋藤俊介取締役 医療ビジネスユニット長
Investors · 2
Frequently asked questions
- What does Synplogen do?
- Synplogen is a synthetic biology startup spun out of Kobe University that offers custom artificial gene synthesis and DNA library construction services using its proprietary OGAB and Combinatorial-OGAB (Combi-OGAB) DNA assembly methods. It also operates a gene-therapy biofoundry that designs, develops, and analyzes gene-therapy products such as viral vectors, including CMC development work.
- Who founded Synplogen?
- Synplogen was founded by 柘植謙爾.
- Who are Synplogen's investors?
- Synplogen's investors include i-nest capital, Kobe University Capital.
- Where is Synplogen headquartered?
- Synplogen is headquartered in Kobe, JP.